IN VITRO
PROFILING
MARKET ORIENTED SCIENCE
HUMAN RESPONSE

OUR FUNCTION

Your decision making partner in human

Cells + Products

Immuno-staining

Flow cytometry

Fluorescence signals

Profiling

OUR SERVICES

PROFILeHIT AN INNOVATIVE PROFILING COMPANY

Cosmetical players – Food supplements producers

ProfileHIT is a French CRO exploring the pharmacological properties of new compounds, coming from natural products (algae, mushrooms, plants…), Medicinal Chemistry, Biotechnologies or from Agro-Food Industry.

Through an innovative approach, ProfileHIT brings an early access to the biological potential of new molecules. Based on its inedite detection-methods, ProfileHIT provides an early access to the potential benefit of a molecule, allowing a fast determination of its future uses or indications.

Furthermore, this screening-strategy enables the exclusion from the pipeline of some of the compounds which would present toxicities over the further testing-procedures, thus enabling the prevention of unnecessary investments for the companies.

ProfileHIT is a French CRO exploring the pharmacological properties of new compounds, coming from natural products (algae, mushrooms, plants…), Medicinal Chemistry, Biotechnologies or from Agro-Food Industry.

Through an innovative approach, ProfileHIT brings an early access to the biological potential of new molecules. Based on its inedite detection-methods, ProfileHIT provides an early access to the potential benefit of a molecule, allowing a fast determination of its future uses or indications.

Furthermore, this screening-strategy enables the exclusion from the pipeline of some of the compounds which would present toxicities over the further testing-procedures, thus enabling the prevention of unnecessary investments for the companies.

« Nous croyons en ce que la Science fait de mieux et nous faisons ce qu’il y a de mieux dans la Science : accélérer l’émergence de nouvelles thérapies »

Mathias CHATELAIS, ProfileHIT CEO.

The « Premium Drug Profiling » offers a fast answer for the Biotechnology companies and the Pharmaceutical Groups regarding the therapeutic response of their future drugs in Human.

ProfileHIT represents a unique opportunity for its customers to directly assess in vitro, the response of a drug candidate on the Human vascular peripheral system, before its first administration in Human.

As our screening-strategy can be done before the pre-clinical phases, it enables to exclude out of the pipeline some of the compounds which could present toxicities over the further testing-procedures.

Thus, this approach enables the prevention of unnecessary investments for the companies.

The « Premium Drug Profiling » offers a fast answer for the Biotechnology companies and the Pharmaceutical Groups regarding the therapeutic response of their future drugs in Human.

ProfileHIT represents a unique opportunity for its customers to directly assess in vitro, the response of a drug candidate on the Human vascular peripheral system, before its first administration in Human.

As our screening-strategy can be done before the pre-clinical phases, it enables to exclude out of the pipeline some of the compounds which could present toxicities over the further testing-procedures.

Thus, this approach enables the prevention of unnecessary investments for the companies.

Biotechnological and Pharmaceutical company

They trust us